Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Latest News
A group of House Republicans are requesting Fiscal Year 2026 spending bills to include language prohibiting federal funding for transgender experiments on animals. Republican...
Latest News
Defense Department civilian employees will no longer need to submit a weekly bulleted list of what they accomplished, which the Department of Government Efficiency...
Latest News
Following news that the House Rules Committee will convene at 1 a.m. on Wednesday morning to take the next steps in advancing President Trump’s...
Stock
The bullish signals stacked up in April and May, but most long-term breadth indicators are still bearish. SPY and QQQ showed signs of capitulation...